Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ballantyne

Showing results (301-310 of 999) with videos related to

Pageof 100
Sort By:
Thrombosis Research|June 11, 2013
Lipoprotein-associated phospholipase A2 and venous thromboembolism: a prospective studyAaron R Folsom, Pamela L Lutsey, Nicholas S Roetker, et al.
Atherosclerosis|February 18, 2014
Attenuated adipose tissue and skeletal muscle inflammation in obese mice with combined CD4+ and CD8+ T cell deficiencyIlvira M Khan, Xiao-Yuan Dai Perrard, Jerry L Perrard, et al.
Journal of the American College of Cardiology|March 8, 2023
Phase 2b Randomized Trial of the Oral PCSK9 Inhibitor MK-0616Christie M Ballantyne, Puja Banka, Gustavo Mendez, et al.
Journal of the American College of Cardiology|March 18, 2025
Effect of Targeting ApoC-III With Plozasiran on Lipoprotein Particle Size and Number in HypertriglyceridemiaChristie M Ballantyne, Daniel Gaudet, Robert S Rosenson, et al.
Medrxiv : the Preprint Server for Health Sciences|April 3, 2026
Heterogeneity in Lipoprotein(a) Profile Changes Across the Menopausal TransitionCatherine A Palmer, Christy L Avery, Christie M Ballantyne, et al.
Contemporary Clinical Trials|August 18, 2006
Heart positive: design of a randomized controlled clinical trial of intensive lifestyle intervention, niacin and fenofibrate for HIV lipodystrophy/dyslipidemiaSusan L Samson, Henry J Pownall, Lynne W Scott, et al.
Diabetes Care|January 30, 2007
Cardiometabolic risk in impaired fasting glucose and impaired glucose tolerance: the Atherosclerosis Risk in Communities StudyJames S Pankow, David K Kwan, Bruce B Duncan, et al.
Diabetes Care|April 30, 2003
Detection of undiagnosed diabetes and other hyperglycemia states: the Atherosclerosis Risk in Communities StudyMaria Inês Schmidt, Bruce B Duncan, Alvaro Vigo, et al.
Circulation|January 7, 1998
Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) studyS J Hwang, C M Ballantyne, A R Sharrett, et al.
Journal of the American College of Cardiology|September 4, 2016
Diastolic Blood Pressure, Subclinical Myocardial Damage, and Cardiac Events: Implications for Blood Pressure ControlJohn W McEvoy, Yuan Chen, Andreea Rawlings, et al.
Pageof 100

Showing results (301-310 of 999) with videos related to

Sort By:
Pageof 100
Thrombosis Research|June 11, 2013
Lipoprotein-associated phospholipase A2 and venous thromboembolism: a prospective studyAaron R Folsom, Pamela L Lutsey, Nicholas S Roetker, et al.
Atherosclerosis|February 18, 2014
Attenuated adipose tissue and skeletal muscle inflammation in obese mice with combined CD4+ and CD8+ T cell deficiencyIlvira M Khan, Xiao-Yuan Dai Perrard, Jerry L Perrard, et al.
Journal of the American College of Cardiology|March 8, 2023
Phase 2b Randomized Trial of the Oral PCSK9 Inhibitor MK-0616Christie M Ballantyne, Puja Banka, Gustavo Mendez, et al.
Journal of the American College of Cardiology|March 18, 2025
Effect of Targeting ApoC-III With Plozasiran on Lipoprotein Particle Size and Number in HypertriglyceridemiaChristie M Ballantyne, Daniel Gaudet, Robert S Rosenson, et al.
Medrxiv : the Preprint Server for Health Sciences|April 3, 2026
Heterogeneity in Lipoprotein(a) Profile Changes Across the Menopausal TransitionCatherine A Palmer, Christy L Avery, Christie M Ballantyne, et al.
Contemporary Clinical Trials|August 18, 2006
Heart positive: design of a randomized controlled clinical trial of intensive lifestyle intervention, niacin and fenofibrate for HIV lipodystrophy/dyslipidemiaSusan L Samson, Henry J Pownall, Lynne W Scott, et al.
Diabetes Care|January 30, 2007
Cardiometabolic risk in impaired fasting glucose and impaired glucose tolerance: the Atherosclerosis Risk in Communities StudyJames S Pankow, David K Kwan, Bruce B Duncan, et al.
Diabetes Care|April 30, 2003
Detection of undiagnosed diabetes and other hyperglycemia states: the Atherosclerosis Risk in Communities StudyMaria Inês Schmidt, Bruce B Duncan, Alvaro Vigo, et al.
Circulation|January 7, 1998
Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) studyS J Hwang, C M Ballantyne, A R Sharrett, et al.
Journal of the American College of Cardiology|September 4, 2016
Diastolic Blood Pressure, Subclinical Myocardial Damage, and Cardiac Events: Implications for Blood Pressure ControlJohn W McEvoy, Yuan Chen, Andreea Rawlings, et al.
Pageof 100